Literature DB >> 18625954

Effect of intravitreous rituximab injections in patients with recurrent ocular lesions associated with central nervous system lymphoma.

Nobuyuki Ohguro1, Noriyasu Hashida, Yasuo Tano.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18625954     DOI: 10.1001/archopht.126.7.1002

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


× No keyword cloud information.
  11 in total

Review 1.  Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium.

Authors:  Chi-Chao Chan; James L Rubenstein; Sarah E Coupland; Janet L Davis; J William Harbour; Patrick B Johnston; Nathalie Cassoux; Valerie Touitou; Justine R Smith; Tracy T Batchelor; Jose S Pulido
Journal:  Oncologist       Date:  2011-11-01

Review 2.  Biology and treatment of primary central nervous system lymphoma.

Authors:  Alain P Algazi; Cigall Kadoch; James L Rubenstein
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

Review 3.  Primary central nervous system lymphoma: essential points in diagnosis and management.

Authors:  Semra Paydas
Journal:  Med Oncol       Date:  2017-03-17       Impact factor: 3.064

4.  [Diagnostics and treatment of primary vitreoretinal lymphoma].

Authors:  N Stübiger; V Kakkassery; E Gundlach; S Winterhalter; U Pleyer
Journal:  Ophthalmologe       Date:  2015-03       Impact factor: 1.059

5.  Efficacy and Complications of Intravitreal Rituximab Injection for Treating Primary Vitreoretinal Lymphoma.

Authors:  Noriyasu Hashida; Nobuyuki Ohguro; Kohji Nishida
Journal:  Transl Vis Sci Technol       Date:  2012-10-22       Impact factor: 3.283

6.  Association between ocular findings and preventive therapy with onset of central nervous system involvement in patients with primary vitreoretinal lymphoma.

Authors:  Noriyasu Hashida; Kei Nakai; Norimitsu Saitoh; Kohji Nishida
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-02-19       Impact factor: 3.117

7.  Primary intraocular lymphoma.

Authors:  Lisa J Faia; Chi-Chao Chan
Journal:  Arch Pathol Lab Med       Date:  2009-08       Impact factor: 5.534

8.  Efficacy and MRI of rituximab and methotrexate treatment in a nude rat model of CNS lymphoma.

Authors:  Kristoph Jahnke; Leslie L Muldoon; Csanad G Varallyay; Seth J Lewin; Robert D Brown; Dale F Kraemer; Carole Soussain; Edward A Neuwelt
Journal:  Neuro Oncol       Date:  2009-01-21       Impact factor: 12.300

9.  Effect of intravitreal methotrexate and rituximab on interleukin-10 levels in aqueous humor of treated eyes with vitreoretinal lymphoma.

Authors:  Harish Raja; Melissa R Snyder; Patrick B Johnston; Brian P O'Neill; Juline N Caraballo; Joseph G Balsanek; Brian E Peters; Paul A Decker; Jose S Pulido
Journal:  PLoS One       Date:  2013-06-04       Impact factor: 3.240

10.  Vitreous and Optic Nerve Infiltration of an Adrenal B Lymphoma.

Authors:  Lucía Galletero Pandelo; Cristina Rodríguez Vidal; Joseba Artaraz; Nerea Martínez-Alday; Alex Fonollosa
Journal:  Case Rep Ophthalmol       Date:  2021-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.